Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
26-07-10	US$0.000001	0.00%	1,101,250

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets Other stock markets 09:30:05 2026-07-10 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 933K 861K 795K 1.51M 102M 1.53M 10.28M 4.04M 50.12M 4.01M 3.92M 172M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.6M 3.32M 3.07M 5.82M 392M 5.91M 39.65M 15.57M 193M 15.44M 15.11M 664M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
17-12-30	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
17-11-29	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
17-09-15	Pazoo, Inc. Announces Executive Changes	CI
17-04-03	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
16-07-14	Pazoo, Inc Implements New Validating of Testing	CI
16-06-18	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
16-04-26	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
16-03-30	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
16-03-15	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
15-11-09	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
15-07-09	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

22-10-28	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
20-12-07	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
18-11-14	Pazoo : Posts Conference Call Recording	PR
18-10-31	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
18-10-11	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Pazoo, Inc. Stock

Stocks

PZOO

US70454Q3048

Healthcare Facilities & Services

Valuation: Pazoo, Inc.

Chart: Pazoo, Inc.

Latest news : Pazoo, Inc.

Press Releases: Pazoo, Inc.

Course Extremes

Managers and Directors: Pazoo, Inc.

Medical & Diagnostic Laboratories

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAZOO, INC.	0.00%	0.00%	-	-	2.69K
NATERA, INC.	-4.22%	-3.35%	+65.25%	+458.79%	38.66B
LABCORP HOLDINGS INC.	-0.30%	-3.54%	+9.14%	+31.51%	22.7B
SONIC HEALTHCARE LIMITED	-0.56%	-0.05%	-21.62%	-38.20%	7.3B
RADNET, INC.	-0.52%	-4.58%	+14.09%	+106.87%	5.16B
DR. LAL PATHLABS LIMITED	+0.49%	+2.86%	+15.57%	+41.51%	2.97B
GENEDX HOLDINGS CORP.	-5.40%	-2.77%	-24.47%	+972.55%	1.95B
NEOGENOMICS, INC.	-4.21%	-6.93%	+88.38%	-16.80%	1.84B
FLEURY S.A.	+6.62%	+4.45%	+29.29%	+1.86%	1.75B
DIAN DIAGNOSTICS GROUP CO.,LTD.	+11.56%	+1.19%	+38.06%	-18.68%	1.84B
Average	+0.35%	-0.81%	+23.74%	+171.05%	8.42B
Weighted average by Cap.	-1.91%	-2.65%	+34.78%	+245.74%

	2016	2017
Net sales	30.52K 26.69K 24.62K 22.74K 43.15K 2.91M 43.87K 294K 116K 1.43M 115K 112K 4.93M	-
Net income	-8.8M -7.69M -7.1M -6.55M -12.44M -839M -12.65M -84.79M -33.3M -413M -33.02M -32.31M -1.42B	-3.54M -3.1M -2.86M -2.64M -5.01M -338M -5.1M -34.17M -13.42M -167M -13.31M -13.02M -573M
Net Debt	3.44M 3.01M 2.78M 2.57M 4.87M 328M 4.95M 33.2M 13.04M 162M 12.93M 12.65M 556M	3.05M 2.66M 2.46M 2.27M 4.31M 291M 4.38M 29.37M 11.53M 143M 11.44M 11.19M 492M

3 years	0		0
5 years	0		0
10 years	0		0.18